Abstract
We developed an autologous, trileaflet tissue valve (“biovalve”) using in-body tissue architecture technology to overcome the disadvantages of current bioprosthetic valves. We designed a novel biovalve with a balloon-expandable stent: the stent biovalve (SBV). This study evaluated the technical feasibility of sutureless aortic valve replacement using the SBV in an orthotopic position, as well as the functionality of the SBV under systemic circulation, in an acute experimental goat model. Three adult goats (54.5–56.1 kg) underwent sutureless AVR under cardiopulmonary bypass (CPB). The technical feasibility and functionality of the SBVs were assessed using angiography, pressure catheterization, and two-dimensional echocardiography. The sutureless AVR was successful in all goats, and all animals could be weaned off CPB. The mean aortic cross-clamp time was 45 min. Angiogram, after weaning the animals off CPB, showed less than mild paravalvular leakage and central leakage was not detected in any of the goats. The mean peak-to-peak pressure gradient was 6.3 ± 5.0 mmHg. Epicardial two-dimensional echocardiograms showed smooth leaflet movement, including adequate closed positions with good coaptation; the open position demonstrated a large orifice area (average aortic valve area 2.4 ± 0.1 cm2). Sutureless AVR, using SBVs, was feasible in a goat model. The early valvular functionalities of the SBV were sufficient; future long-term experiments are needed to evaluate its durability and histological regeneration potential.
This is a preview of subscription content, log in via an institution to check access.
References
Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79:1072–80.
Furukawa H, Tanemoto K. Current status and future perspectives of prosthetic valve selection for aortic valve replacement. Gen Thorac Cardiovasc Surg. 2014;62:19–23.
Saleeb SF, Newburger JW, Geva T, Baird CW, Gauvreau K, Padera RF, Del Nido PJ, Borisuk MJ, Sanders SP, Mayer JE. Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults. Circulation. 2014;130:51–60.
Cebotari S, Tudorache I, Ciubotaru A, Boethig D, Sarikouch S, Goerler A, Lichtenberg A, Cheptanaru E, Barnaciuc S, Cazacu A, Maliga O, Repin O, Maniuc L, Breymann T, Haverich A. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation. 2011;124(11 Suppl):S115–23.
Emmert MY, Weber B, Wolint P, Behr L, Sammut S, Frauenfelder T, Frese L, Scherman J, Brokopp CE, Templin C, Grünenfelder J, Zünd G, Falk V, Hoerstrup SP. Stem cell-based transcatheter aortic valve implantation: first experiences in a pre-clinical model. JACC Cardiovasc Interv. 2012;5:874–83.
Konertz W, Dohmen PM, Liu J, Beholz S, Dushe S, Posner S, Lembcke A, Erdbrügger W. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis. 2005;14:78–81.
Konuma T, Devaney EJ, Bove EL, Gelehrter S, Hirsch JC, Tavakkol Z, Ohye RG. Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann Thorac Surg. 2009;88:849–54.
Nakayama Y, Takewa Y, Sumikura H, Yamanami M, Matsui Y, Oie T, Kishimoto Y, Arakawa M, Ohmuma K, Tajikawa T, Kanda K, Tatsumi E. In-body tissue-engineered aortic valve (biovalve type VII) architecture based on 3D printer molding. J Biomed Mater Res B Appl Biomater. 2014;. doi:10.1002/jbm.b.33186.
Hayashida K, Kanda K, Yaku H, Ando J, Nakayama Y. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model. J Thorac Cardiovasc Surg. 2007;134:152–9.
Yamanami M, Yahata Y, Uechi M, Fujiwara M, Ishibashi-Ueda H, Kanda K, Watanabe T, Tajikawa T, Ohba K, Yaku H, Nakayama Y. Development of a completely autologous valved conduit with the sinus of Valsalva using in-body tissue architecture technology: a pilot study in pulmonary valve replacement in a beagle model. Circulation. 2010;122(11 Suppl):S100–6.
Takewa Y, Yamanami M, Kishimoto Y, Arakawa M, Kanda K, Matsui Y, Oie T, Ishibashi-Ueda H, Tajikawa T, Ohba K, Yaku H, Taenaka Y, Tatsumi E, Nakayama Y. In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model. J Artif Organs. 2013;16:176–84.
Sumikura H, Nakayama Y, Ohnuma K, Takewa Y, Tatsumi E. In vitro evaluation of a novel autologous aortic valve (biovalve) with a pulsatile circulation circuit. Artif Organs. 2014;38:282–9.
Shrestha M, Folliguet TA, Pfeiffer S, Meuris B, Carrel T, Bechtel M, Flameng WJ, Fischlein T, Laborde F, Haverich A. Aortic valve replacement and concomitant procedures with the perceval valve: results of European trials. Ann Thorac Surg. 2014;98:1294–300.
Gilmanov D, Miceli A, Ferrarini M, Farneti P, Murzi M, Solinas M, Glauber M. Aortic valve replacement through right anterior minithoracotomy: can sutureless technology improve clinical outcomes? Ann Thorac Surg. 2014;. doi:10.1016/j.athoracsur.2014.05.092.
Acknowledgments
The authors thank Dr. Nobumasa Katagiri, Ms. Konomi Togo, and Dr. Yutaka Fujii for their participation in this study as perfusionists, and we thank Goodman Co. for providing the stent. This study was presented at the 52nd Annual Meeting of the Japanese Society for Artificial Organs on October 18, 2014, in Sapporo, Japan.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kishimoto, S., Takewa, Y., Nakayama, Y. et al. Sutureless aortic valve replacement using a novel autologous tissue heart valve with stent (stent biovalve): proof of concept. J Artif Organs 18, 185–190 (2015). https://doi.org/10.1007/s10047-015-0817-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-015-0817-1